CARS2

Chr 13AR

cysteinyl-tRNA synthetase 2, mitochondrial

Also known as: COXPD27, cysRS

This gene encodes a putative member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of cysteine to tRNA molecules. A splice-site mutation in this gene has been associated with a novel progressive myoclonic epilepsy disease with similar symptoms to MERRF syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.841 OMIM phenotype
Clinical SummaryCARS2
🧬
Gene-Disease Validity (ClinGen)
mitochondrial disease · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
6 unique Pathogenic / Likely Pathogenic· 386 VUS of 863 total submissions
💊
Clinical Trials
3 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.84LOEUF
pLI 0.000
Z-score 2.23
OE 0.55 (0.370.84)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.25Z-score
OE missense 0.96 (0.881.05)
318 obs / 330.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.55 (0.370.84)
00.351.4
Missense OE?0.96 (0.881.05)
00.61.4
Synonymous OE?1.08
01.21.6
LoF obs/exp: 16 / 28.9Missense obs/exp: 318 / 330.8Syn Z: -0.73
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCARS2-related epileptic encephalopathy with complex movement disorder and regressionLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6646th %ile
GOF
0.6053th %ile
LOF
0.3259th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

863 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic5
VUS386
Likely Benign357
Benign71
Conflicting24
1
Pathogenic
5
Likely Pathogenic
386
VUS
357
Likely Benign
71
Benign
24
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
0
0
1
Likely Pathogenic
4
1
0
0
5
VUS
33
313
38
2
386
Likely Benign
0
4
171
182
357
Benign
1
6
60
4
71
Conflicting
24
Total39324269188844

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

111 pathogenic / likely-pathogenic (of 126) ClinVar copy-number / structural variants overlap CARS2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CARS2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.